First Tracks Biotherapeutics reports trailing twelve-month earnings per share (EPS) of $-4.71.

How does TRAX stock react to earnings?

First Tracks Biotherapeutics's stock price reaction to earnings is tracked over the prior 8 reports including average 1-day move, positive reaction rate, and largest single-day move.

TRAX

First Tracks Biotherapeutics

NASDAQ: TRAX · HEALTHCARE · BIOTECHNOLOGY

$23.27

-1.57% today

Updated 2026-04-30

Market cap

$821.46M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-4.71

Dividend yield

—

52W range

$11 – $27

Volume

0.7M

Market cap

$821.46M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-4.71

Dividend yield

—

52W range

$11 – $27

Volume

0.7M

First Tracks Biotherapeutics (TRAX) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak

—

Last 8 quarters

Avg EPS surprise

—

Last 4 quarters

Revenue YoY growth

—

Most recent quarter

EPS YoY growth

—

Most recent quarter

Quarterly earnings history

Fiscal quarter ending	EPS estimate	EPS actual	Surprise	Revenue	YoY revenue

First Tracks Biotherapeutics

First Tracks Biotherapeutics (TRAX) Earnings

Quarterly earnings history

Frequently asked questions